IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial Advertise
 

Search About Journals, Conferences, and Book Series


Cardiovascular Drugs and Therapy- Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on October 4, 2021

Impact Factor

3.727

h-Index

 69

Rank

 3749

SJR

 1.108

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Cardiovascular Drugs and Therapy
Abbreviation Cardiovasc. Drugs Ther.
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)
h-index 69
Overall Rank/Ranking 3749
SCImago Journal Rank (SJR) 1.108
Impact Score 2.77
Impact Factor 3.727 (2020)
Publisher Kluwer Academic Publishers
Country Netherlands
ISSN 15737241, 09203206


About Cardiovascular Drugs and Therapy


Cardiovascular Drugs and Therapy is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Kluwer Academic Publishers. The overall rank of Cardiovascular Drugs and Therapy is 3749. According to SCImago Journal Rank (SJR), this journal is ranked 1.108. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 69. The best quartile for this journal is Q1.

The ISSN of Cardiovascular Drugs and Therapy journal is 15737241, 09203206. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular Drugs and Therapy is cited by a total of 779 articles during the last 3 years (Preceding 2020).


Cardiovascular Drugs and Therapy Impact Factor 2020-2021


The impact factor (IF) 2020 of Cardiovascular Drugs and Therapy is 3.727, which is computed in 2021 as per it's definition. Cardiovascular Drugs and Therapy IF is decreased by a factor of 0.34 and approximate percentage change is -8.41% when compared to preceding year 2019, which shows a falling trend. The impact factor (If), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Web of Science data.

Table Setting

Impact Factor Trend


Year wise Impact Factor (IF) of Cardiovascular Drugs and Therapy. Based on Web of Science data.


Year Impact Factor (IF)
2021/2022Coming Soon
2020 3.727
2019 4.069
2018 4.181
2017 2.771
2016 2.820
2015 3.189
2014 3.189
2013 2.952
2012 2.673
2011 3.130
2010 3.098

Cardiovascular Drugs and Therapy Impact Score 2020-2021


The impact score (IS) 2020 of Cardiovascular Drugs and Therapy is 2.77, which is computed in 2021 as per its definition. Cardiovascular Drugs and Therapy IS is decreased by a factor of 0.81 and approximate percentage change is -22.63% when compared to preceding year 2019, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cardiovascular Drugs and Therapy Impact Score 2021 Prediction


IS 2020 of Cardiovascular Drugs and Therapy is 2.77. If the same downward trend persists, impact score of joule may fall in 2021 as well.


Impact Score Trend


Year wise Impact Score (IS) of Cardiovascular Drugs and Therapy. Based on Scopus data.


Year Impact Score (IS)
2021/2022 Coming Soon
2020 2.77
2019 3.58
2018 3.81
2017 2.64
2016 2.50
2015 2.76
2014 2.81

Cardiovascular Drugs and Therapy h-index


  Table Setting

Cardiovascular Drugs and Therapy has an h-index of 69. It means 69 articles of this journal have more than 69 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cardiovascular Drugs and Therapy ISSN


The ISSN of Cardiovascular Drugs and Therapy is 15737241, 09203206. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cardiovascular Drugs and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Cardiovascular Drugs and Therapy is 3749. According to SCImago Journal Rank (SJR), this journal is ranked 1.108. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Cardiovascular Drugs and Therapy Publisher


Table Setting

Cardiovascular Drugs and Therapy is published by Kluwer Academic Publishers. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1987-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cardiovascular Drugs and Therapy is Cardiovasc. Drugs Ther.. This abbreviation ('Cardiovasc. Drugs Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cardiovascular Drugs and Therapy


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Factor, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Studies in Continuing Education journal 5522 Routledge 32 1.53
Journal of Zoo and Wildlife Medicine journal 11675 American Association of Zoo Veterinarians 45 0.73
Journal of Operator Theory journal 5911 Theta Foundation 40 1.61
L' Orthodontie française journal 20028 EDP Sciences 8 0.21
2018 International Conference on Advances in Big Data, Computing and Data Communication Systems, icABCD 2018 conference and proceedings 22018 6 0.82
Nederlands Tijdschrift voor Geneeskunde journal 23484 Bohn Stafleu van Loghum 35 0.11
Scandinavian Journal of History journal 14873 Taylor and Francis Ltd. 20 0.56
Foundations and Trends in Technology, Information and Operations Management journal 16747 Now Publishers Inc 14 0.44
Proceedings - 2017 IEEE International Conference on Cloud and Autonomic Computing, ICCAC 2017 conference and proceedings 17463 4 0.00
Journal of Austrian studies journal 31434 University of Nebraska Press 4 0.03

Check complete list



Year wise Impact Factor (IF) of Cardiovascular Drugs and Therapy

Impact Factor Table

Year Impact Factor (IF)
2021/2022Coming Soon
2020 3.727
2019 4.069
2018 4.181
2017 2.771
2016 2.820
2015 3.189
2014 3.189
2013 2.952
2012 2.673
2011 3.130
2010 3.098



Year wise Impact Score (IF) of Cardiovascular Drugs and Therapy

Impact Score Table

Year Impact Score (IS)
2021/2022 Coming Soon
2020 2.77
2019 3.58
2018 3.81
2017 2.64
2016 2.50
2015 2.76
2014 2.81



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Journal of the American College of Cardiology
Elsevier USA | United States

Circulation
Lippincott Williams and Wilkins Ltd. | United States

JACC: Heart Failure
Elsevier BV | Netherlands

JAMA Cardiology
American Medical Association | United States

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

Nature Reviews Cardiology
Nature Publishing Group | United Kingdom

European Journal of Heart Failure
Wiley-Blackwell | United States

Circulation Research
Lippincott Williams and Wilkins Ltd. | United States

European Heart Journal
Oxford University Press | United Kingdom

Journal of Heart and Lung Transplantation
Elsevier USA | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All